Taysha Gene Therapies, Inc.

Informe acción NasdaqGS:TSHA

Capitalización de mercado: US$313.6m

Salud financiera de hoja de balance de Taysha Gene Therapies

Salud financiera controles de criterios 5/6

Taysha Gene Therapies has a total shareholder equity of $108.9M and total debt of $37.8M, which brings its debt-to-equity ratio to 34.8%. Its total assets and total liabilities are $200.4M and $91.5M respectively.

Información clave

34.8%

Ratio deuda-patrimonio

US$37.84m

Deuda

Ratio de cobertura de interesesn/a
EfectivoUS$172.74m
PatrimonioUS$108.87m
Total pasivoUS$91.53m
Activos totalesUS$200.39m

Actualizaciones recientes sobre salud financiera

Recent updates

Taysha Gene Therapies: Unjustified Sell-Off - Enough Cash Runway And Promising Rett Syndrome Data

Oct 14

More Unpleasant Surprises Could Be In Store For Taysha Gene Therapies, Inc.'s (NASDAQ:TSHA) Shares After Tumbling 37%

Jun 27
More Unpleasant Surprises Could Be In Store For Taysha Gene Therapies, Inc.'s (NASDAQ:TSHA) Shares After Tumbling 37%

Taysha Gene Therapies: Latest Rett Data Checks Momentum, Road Ahead Rocky

Jun 20

Growth Investors: Industry Analysts Just Upgraded Their Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Revenue Forecasts By 23%

Apr 20
Growth Investors: Industry Analysts Just Upgraded Their Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Revenue Forecasts By 23%

What Taysha Gene Therapies, Inc.'s (NASDAQ:TSHA) 55% Share Price Gain Is Not Telling You

Mar 21
What Taysha Gene Therapies, Inc.'s (NASDAQ:TSHA) 55% Share Price Gain Is Not Telling You

Taysha: Initial Rett Syndrome Data Leads To Other 2024 Catalysts

Mar 20

Taysha: Produces Solid Data But Has Abandoned Programs

Feb 06

Taysha Gene Therapies Gets A 'Thumbs Up'

Mar 07

Análisis de la situación financiera

Pasivos a corto plazo: TSHA's short term assets ($178.5M) exceed its short term liabilities ($34.2M).

Pasivo a largo plazo: TSHA's short term assets ($178.5M) exceed its long term liabilities ($57.3M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: TSHA has more cash than its total debt.

Reducción de la deuda: Insufficient data to determine if TSHA's debt to equity ratio has reduced over the past 5 years.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: TSHA has sufficient cash runway for more than a year based on its current free cash flow.

Pronóstico de cash runway: TSHA has sufficient cash runway for 1.9 years if free cash flow continues to reduce at historical rates of 7.1% each year.


Descubre empresas con salud financiera